Evidence map›Paper›PMID 36133420›Full record

ArticleRespiratory medicine case reports2022

Antigen avoidance and environmental inhalation challenge for successful diagnosis of fibrotic hypersensitivity pneumonitis mimicking idiopathic pulmonary fibrosis.

Yasuhiro Ito, Seiichi Miwa, Hiroshi Hayakawa, Tomoko Oshima, Tatsuru Eihuku, Eriko Iwaizumi, Hisano Ohba, Kaoru Fujita, Miho Kanai, Masahiro Shirai

Open access · goldAbstract readCase Reports
In one paragraph

Article in Respiratory medicine case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yasuhiro ItoDepartment of Respiratory Medicine, National Hospital Organization, Tenryu Hospital, Hamamatsu, Japan.
Seiichi MiwaDepartment of Respiratory Medicine, National Hospital Organization, Tenryu Hospital, Hamamatsu, Japan.
Hiroshi HayakawaDepartment of Respiratory Medicine, National Hospital Organization, Tenryu Hospital, Hamamatsu, Japan.
Tomoko OshimaDepartment of Respiratory Medicine, National Hospital Organization, Tenryu Hospital, Hamamatsu, Japan.
Tatsuru EihukuDepartment of Respiratory Medicine, National Hospital Organization, Tenryu Hospital, Hamamatsu, Japan.
Eriko IwaizumiDepartment of Respiratory Medicine, National Hospital Organization, Tenryu Hospital, Hamamatsu, Japan.
Hisano OhbaDepartment of Respiratory Medicine, National Hospital Organization, Tenryu Hospital, Hamamatsu, Japan.
Kaoru FujitaDepartment of Respiratory Medicine, National Hospital Organization, Tenryu Hospital, Hamamatsu, Japan.
Miho KanaiDepartment of Respiratory Medicine, National Hospital Organization, Tenryu Hospital, Hamamatsu, Japan.
Masahiro ShiraiDepartment of Respiratory Medicine, National Hospital Organization, Tenryu Hospital, Hamamatsu, Japan.
National Hospital Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 77-year-old man was initially diagnosed with idiopathic pulmonary fibrosis (IPF) and treated with anti-fibrotic nintedanib. Despite undergoing anti-fibrotic treatment for one year, his condition remained unstable. The patient was admitted to our hospital for exertional dyspnea. We performed an exposure assessment, including 2-week antigen avoidance and an environmental inhalation challenge, and successfully re-diagnosed him with fibrotic hypersensitivity pneumonitis (HP), known as chronic farmer's lung. Adding oral glucocorticoids to the nintedanib treatment improved his condition. Although antigen avoidance and environmental inhalation challenge tests are not standardized, they may be useful for diagnosing fibrotic HP when properly applied.

Indexed as

Antigen avoidanceFarmer's lungFibrotic hypersensitivity pneumonitisIdiopathic pulmonary fibrosisInhalation challenge

Identifiers

PMID36133420
PMCPMC9483807
OpenAlexW4295339021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.